The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Sarena Francis Willard since year 2005.
The trader's CIK number is 1423786.
At the time of this reporting, Sarena Francis Willard is the Chief Strategy Officer of Five Prime Therapeutics Inc .
(stock ticker symbol FPRX).
See this page for all insider trading activities at Five Prime Therapeutics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-01-18||FPRX||Five Prime Therapeutics Inc||Option Ex||3,636||5.54||20,143|
|2017-01-18||FPRX||Five Prime Therapeutics Inc||Sale||3,636||47.39||172,310|
|2016-11-28||FPRX||Five Prime Therapeutics Inc||Sale||1,710||60.14||102,839|
|2016-11-28||FPRX||Five Prime Therapeutics Inc||Option Ex||1,710||5.54||9,473|
|2016-11-23||FPRX||Five Prime Therapeutics Inc||Option Ex||13,465||6.89||92,773|
|2016-11-23||FPRX||Five Prime Therapeutics Inc||Sale||13,465||60.23||810,996|
|2016-11-25||FPRX||Five Prime Therapeutics Inc||Option Ex||21,189||6.21||131,689|
|2016-11-25||FPRX||Five Prime Therapeutics Inc||Sale||21,189||60.48||1,281,510|
|2016-03-29||FPRX||Five Prime Therapeutics Inc||Option Ex||4,450||8.49||37,780|
|2016-03-30||FPRX||Five Prime Therapeutics Inc||Option Ex||5,550||8.49||47,119|
|2016-03-29||FPRX||Five Prime Therapeutics Inc||Sale||4,450||40.00||178,000|
|2016-03-30||FPRX||Five Prime Therapeutics Inc||Sale||5,550||40.01||222,055|
|2016-01-27||FPRX||Five Prime Therapeutics Inc||Option Ex||30,000||8.64||259,200|
|2016-01-27||FPRX||Five Prime Therapeutics Inc||Sale||30,000||35.30||1,059,150|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sarena Francis Willard (Chief Strategy Officer of Five Prime Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.